Dai-ichi Karkaria shareholders approve ₹1.50 dividend at AGM

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Shareholders approved a final dividend of ₹1.50 per equity share for FY26
  • All six ordinary resolutions passed unanimously with zero votes against
  • Material related-party transactions with CXDI and IOCL approved up to ₹60 crore each
  • Promoter group held 47.67 lakh shares and voted 100% in favor of non-RPT resolutions
powered bylight_fuzz_icon
49381644

*this image is generated using AI for illustrative purposes only.

**Dai-ichi Karkaria Limited** shareholders approved a final dividend of ₹1.50 per equity share for FY26 at the company’s 66th Annual General Meeting held on August 27, 2026. The meeting, conducted via video conferencing, saw unanimous support for all proposed resolutions.

The company secured full backing from voting members across six ordinary resolutions. The dividend payout represents a 15% return on the face value of ₹10 per share. Shareholders also ratified the audited financial statements for the fiscal year ended March 31, 2026.

Voting Results Overview

The scrutinizer’s report, filed pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, confirms that all resolutions were passed with the requisite majority. Central Depository Services (India) Limited (CDSL) facilitated the e-voting process.

Resolution Description Votes For Votes Against Status
1 Adoption of Audited Financial Statements (FY26) 48,27,209 0 Passed
2 Declaration of Final Dividend (₹1.50/share) 48,27,209 0 Passed
3 Re-appointment of Director Mrs. Shernaz Vakil 48,27,209 0 Passed
4 Ratification of Cost Auditor Remuneration 48,27,209 0 Passed
5 Approval of Related Party Transactions with CXDI 59,909 0 Passed
6 Approval of Related Party Transactions with IOCL 59,909 0 Passed

Governance and Compliance

Mrs. Shernaz Vakil was reappointed as a director after retiring by rotation. The board also ratified the remuneration payable to M/s. Diwanji & Associates, Cost Accountants, for the financial year ending March 31, 2027.

Shareholders approved material related party transactions with two entities:

  • ChampionX Dai-ichi India Private Limited (CXDI)
  • Indian Oxides and Chemicals Private Limited (IOCL)

These specific resolutions received votes from 42 members representing 59,909 shares, reflecting the abstention or exclusion of interested parties as per regulatory norms. No invalid votes were recorded in any resolution.

Historical Stock Returns for Dai-ichi Karkaria

1 Day5 Days1 Month6 Months1 Year5 Years
-0.97%+8.60%+13.34%0.0%0.0%0.0%

How does the 15% dividend yield compare to industry peers, and is this payout ratio sustainable given Dai-ichi Karkaria's projected earnings for FY27?

What strategic impact will the approved related party transactions with ChampionX Dai-ichi India and Indian Oxides have on the company's operational efficiency or revenue streams?

With Mrs. Shernaz Vakil reappointed as director, what specific governance initiatives or strategic shifts can shareholders expect from the board in the upcoming fiscal year?

Dai-ichi Karkaria Q1FY27 net profit up 178% to ₹6.09 crore on revenue growth

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights

Dai-ichi Karkaria Limited posted a Q1FY27 standalone net profit of ₹6.09 crore, reversing a ₹2.19 crore loss in the prior year. Revenue grew 46.6% to ₹57.84 crore, led by the oilfield chemicals segment which contributed over half of sales. The company also commissioned new ethoxylation capacity at its Dahej plant to support future growth.

powered bylight_fuzz_icon
48166008

*this image is generated using AI for illustrative purposes only.

Dai-ichi Karkaria Limited reported a significant turnaround in profitability for the first quarter of FY27, with standalone net profit rising to ₹6.09 crore from a net loss of ₹2.19 crore in Q1FY26. The Mumbai-based specialty chemicals manufacturer saw its revenue from operations expand by 46.6% year-on-year to ₹57.84 crore, driven by higher operational volumes and improved pricing dynamics.

The Board of Directors approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, at a meeting held on August 13, 2026. The results were reviewed by the Audit Committee and subjected to a limited review by the statutory auditors, B S R & Co. LLP.

Financial Performance

On a consolidated basis, the group recorded a net profit of ₹2.93 crore for the quarter, compared to a negligible profit of ₹0.02 crore in the same period last year. This improvement was bolstered by a share of profit from joint ventures amounting to ₹0.89 crore, up from ₹0.53 crore in Q1FY26.

Metric Q1FY27 (Standalone) Q1FY26 (Standalone) Change
Revenue from operations ₹57.84 crore ₹39.45 crore +46.6%
Other income ₹5.51 crore ₹3.49 crore +57.9%
Total Income ₹63.35 crore ₹42.94 crore +47.5%
Total Expenses ₹54.85 crore ₹40.93 crore +34.0%
Net Profit/Loss ₹6.09 crore (₹2.19 crore) Turnaround

Revenue growth outpaced expense inflation, with total expenses rising 34.0% year-on-year to ₹54.85 crore. Cost of materials consumed increased to ₹40.30 crore from ₹31.75 crore, while employee benefits expenses rose modestly to ₹7.14 crore from ₹6.49 crore.

Segment Highlights

Oilfield Chemicals remained the largest business segment, contributing over half of quarterly revenue, supported by healthy upstream demand across select international markets. While certain downstream product categories were affected by geopolitical developments in the Middle East impacting customer procurement and project timelines, the segment continued to demonstrate resilience.

The Home & Personal Care segment recorded strong growth during the quarter, supported by a growing customer relationship with increased export demand and ongoing new product development. Agrochemicals continued its seasonal recovery, with customer sampling and application development activity progressing well through the internal application laboratory. Paints & Coatings and Textiles saw softer demand during the quarter on account of macroeconomic and input cost pressures, though early signs of improvement are visible as the company enters the second quarter.

Capacity Expansion

On the manufacturing front, the company successfully commissioned an additional ethylene oxide reactor at its Dahej facility during the quarter, strengthening production capabilities and flexibility to serve customers across ethoxylated product categories. Commercialising this expanded capacity, alongside additional oilfield production capacity added during the quarter, remains a key priority through the remainder of FY27.

What the Numbers Show

A key driver of the bottom-line improvement was the surge in other income, which jumped 57.9% year-on-year to ₹5.51 crore. In Q1FY27, other income constituted approximately 8.7% of total income, compared to 8.1% in the prior year, indicating that non-operational gains contributed meaningfully to the top-line expansion alongside core business growth.

The company operates in a single reportable segment: Specialty Chemicals. There were no exceptional items recorded in the current quarter. For the previous full fiscal year (FY26), the company had accounted for a one-time impact of ₹20 lakh related to new labour codes as an exceptional item.

Earnings per share (EPS) on a standalone basis stood at ₹8.18, a significant improvement from the loss of ₹2.94 per share in Q1FY26. On a consolidated basis, EPS was ₹3.93 against ₹0.03 in the corresponding quarter of the previous year.

Historical Stock Returns for Dai-ichi Karkaria

1 Day5 Days1 Month6 Months1 Year5 Years
-0.97%+8.60%+13.34%0.0%0.0%0.0%

How will the newly commissioned ethylene oxide reactor at the Dahej facility impact production costs and margins for ethoxylated products in Q2FY27?

To what extent will ongoing geopolitical tensions in the Middle East continue to suppress demand in the Oilfield Chemicals segment, and are there alternative markets being targeted to offset this risk?

Can the significant surge in 'other income' be sustained in subsequent quarters, or is it likely to normalize as a one-off benefit?

More News on Dai-ichi Karkaria

1 Year Returns:0.00%